Ogkologos

4397 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Spring Budget 2023: What does it mean for the mission to...

Ogkologos - 15 Μαρτίου, 2023

Women in Science: Celebrating with our Women of Influence initiative

Ogkologos - 15 Μαρτίου, 2023

HRQoL Data Support the Benefit of Adding Pembrolizumab to Chemotherapy in...

Ogkologos - 15 Μαρτίου, 2023

What to Know About Cancer Clinical Trial Matching Programs

Ogkologos - 14 Μαρτίου, 2023

KRASG12 Mutations Are Biomarkers for Reduced Overall Survival Benefit of Treatment...

Ogkologos - 14 Μαρτίου, 2023

Estimate of the Global Economic Cost of the Most Prevalent Cancers...

Ogkologos - 13 Μαρτίου, 2023

ESMO Congresses in March: Sarcoma and Rare Cancers Congress and European...

Ogkologos - 10 Μαρτίου, 2023

A career forged in team science

Ogkologos - 10 Μαρτίου, 2023

“Nothing about us without us”: Why we’re working in partnership with...

Ogkologos - 10 Μαρτίου, 2023

EMA Recommends Granting a Marketing Authorisation for Akeega, Fixed-Dose Combinations of...

Ogkologos - 10 Μαρτίου, 2023

1...144145146...440 Σελίδα 145 από 440

MOST POPULAR

FDA Approves Talazoparib with Enzalutamide for HRR Gene-Mutated Metastatic Castration-Resistant Prostate...

6 Ιουλίου, 2023

EMA Recommends Extension of Indications for Ponatinib Associated with a New...

7 Αυγούστου, 2026

Efficacy, Safety, and Translational Data from Durvalumab Plus Ceralasertib in Advanced/Metastatic...

19 Φεβρουαρίου, 2024

Off Target: Investigating the Abscopal Effect as a Treatment for Cancer

28 Ιανουαρίου, 2020

Φόρτωση περισσοτέρων

Spring Budget 2023: What does it mean for the mission to...

Women in Science: Celebrating with our Women of Influence initiative

HRQoL Data Support the Benefit of Adding Pembrolizumab to Chemotherapy in...

What to Know About Cancer Clinical Trial Matching Programs

KRASG12 Mutations Are Biomarkers for Reduced Overall Survival Benefit of Treatment...

Estimate of the Global Economic Cost of the Most Prevalent Cancers...

ESMO Congresses in March: Sarcoma and Rare Cancers Congress and European...

A career forged in team science

“Nothing about us without us”: Why we’re working in partnership with...

EMA Recommends Granting a Marketing Authorisation for Akeega, Fixed-Dose Combinations of...

MOST POPULAR

FDA Approves Talazoparib with Enzalutamide for HRR Gene-Mutated Metastatic Castration-Resistant Prostate...

EMA Recommends Extension of Indications for Ponatinib Associated with a New...

Efficacy, Safety, and Translational Data from Durvalumab Plus Ceralasertib in Advanced/Metastatic...

Off Target: Investigating the Abscopal Effect as a Treatment for Cancer

HOT NEWS

Toxin-Based Drug Moxetumomab Pasudotox May Be New Option for Rare Leukemia

POT1 Mutations Associated with Long Telomere Length Confer a Predisposition to...

Study Identifies Potential Warning Signs of Colorectal Cancer in Younger Adults

Avelumab Ineffective in Patients with MSS Endometrial Cancer Carrying TP53 Mutation

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ